Hi ferrisb... totally agree.
From the ann.,:-
Placement details
• 625,000 new ordinary shares (as noted above);
• 500,000 initial unlisted Options, expiring 4 months after issue with an exercise price of $10
(Initial Options); and
• subject to shareholder approval under ASX listing rule 7.1, 330,000 unlisted 2-year Options
with an exercise price of $15 (Further Options). These Further Options will vest only if all
Initial Options have been exercised. If shareholder approval is not obtained and the Initial
Options have been exercised, Investors will instead receive a cash payment of $1.25 per
Further Option.
My bolding-- and not clear on the 'Investors ..........' - The L1 Cap or 'investors' us ! Nah has to be L1 Cap ?
- Forums
- ASX - By Stock
- AVR
- Ann: Capital Raise
Ann: Capital Raise, page-9
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online